company background image
TFFP

TFF Pharmaceuticals NasdaqGM:TFFP Stock Report

Last Price

US$0.75

Market Cap

US$27.1m

7D

-7.4%

1Y

-88.4%

Updated

23 Mar, 2023

Data

Company Financials +

TFF Pharmaceuticals, Inc.

NasdaqGM:TFFP Stock Report

Mkt Cap: US$27.1m

TFFP Stock Overview

About the company

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company’s lead drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as cannabidiol substance for the treatment of various epilepsy syndromes, as well as anxiety, insomnia, and various pain; Inhaled SARS-CoV2 Monoclonal Antibody for the treatment of patients with COVID-19 infections; Niclosamide Inhalation Powder to treat tapeworm infections in humans, as well as COVID-19 disease; and other vaccines. The company has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop inhaled SARS-CoV2 monoclonal antibody; and a licensing and collaboration agreement with UNION therapeutics A/S. The company was incorporated in 2018 and is based in Austin, Texas.

Snowflake Analysis

TFFP fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

TFF Pharmaceuticals, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for TFF Pharmaceuticals
Historical stock prices
Current Share PriceUS$0.75
52 Week HighUS$7.70
52 Week LowUS$0.62
Beta1.21
1 Month Change13.64%
3 Month Change-18.30%
1 Year Change-88.44%
3 Year Change-78.63%
5 Year Changen/a
Change since IPO-85.21%

Recent News & Updates

Recent updates

Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans?

Sep 27
Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans?

TFF Pharma: The Potential Is Still Very Much Present

Aug 29

TFF Pharmaceuticals: Q3 Data Is Pivotal In So Many Ways

Aug 09

TFF Pharmaceuticals expands R&D operations with new Austin facility

Jul 14

TFF Pharmaceuticals: A Highly Attractive Basket Of Options

May 23

We Think TFF Pharmaceuticals (NASDAQ:TFFP) Needs To Drive Business Growth Carefully

May 17
We Think TFF Pharmaceuticals (NASDAQ:TFFP) Needs To Drive Business Growth Carefully

Here's Why We're Not Too Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Situation

Jan 06
Here's Why We're Not Too Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Situation

TFF Pharmaceuticals: Upside Catalysts Starting To Show Up Amid Omicron, But Timidly

Dec 02

Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

Sep 16
Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

TFF Pharmaceuticals: Cautiously Optimistic

Sep 09

TFF Pharma's Platform Is Highly Relevant In The Battle Against The Pandemic

Jul 27

TFF Pharmaceuticals: Looking Attractive At These Prices

Jun 03

Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

Mar 30
Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

How Much Of TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Do Insiders Own?

Feb 23
How Much Of TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Do Insiders Own?

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Insiders Increased Their Holdings

Jan 19
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Insiders Increased Their Holdings

Dosing underway TFF Pharma's mid-stage study with inhaled voriconazole

Dec 15

Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

Dec 15
Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

TFF Pharma inks development pact with Augmenta for COVID-19 therapies

Nov 02

Shareholder Returns

TFFPUS PharmaceuticalsUS Market
7D-7.4%-1.3%0.8%
1Y-88.4%-5.3%-14.2%

Return vs Industry: TFFP underperformed the US Pharmaceuticals industry which returned -5.3% over the past year.

Return vs Market: TFFP underperformed the US Market which returned -14.2% over the past year.

Price Volatility

Is TFFP's price volatile compared to industry and market?
TFFP volatility
TFFP Average Weekly Movement15.7%
Pharmaceuticals Industry Average Movement10.8%
Market Average Movement6.5%
10% most volatile stocks in US Market16.5%
10% least volatile stocks in US Market3.0%

Stable Share Price: TFFP is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 16% a week.

Volatility Over Time: TFFP's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.

TFF Pharmaceuticals, Inc. Fundamentals Summary

How do TFF Pharmaceuticals's earnings and revenue compare to its market cap?
TFFP fundamental statistics
Market CapUS$27.14m
Earnings (TTM)-US$34.45m
Revenue (TTM)US$195.02k

139.2x

P/S Ratio

-0.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
TFFP income statement (TTM)
RevenueUS$195.02k
Cost of RevenueUS$21.26m
Gross Profit-US$21.06m
Other ExpensesUS$13.38m
Earnings-US$34.45m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.95
Gross Margin-10,801.04%
Net Profit Margin-17,663.02%
Debt/Equity Ratio0%

How did TFFP perform over the long term?

See historical performance and comparison